Adam K. Simpson - 28 Mar 2022 Form 4 Insider Report for Icosavax, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
28 Mar 2022
Net transactions value
+$4,023
Form type
4
Filing time
30 Mar 2022, 18:42:19 UTC
Previous filing
14 Feb 2022
Next filing
06 Jul 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Options Exercise $4,023 +4,789 +2.2% $0.8400* 220,482 28 Mar 2022 Direct
holding ICVX Common Stock 531,576 28 Mar 2022 By family trust
holding ICVX Common Stock 129,032 28 Mar 2022 By family trust
holding ICVX Common Stock 129,032 28 Mar 2022 By family trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICVX Stock Option (Right to Buy) Options Exercise $0 -4,789 -8% $0.000000 55,081 28 Mar 2022 Common Stock 4,789 $0.8400 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares subject to the option vested on 2/21/2021, and 1/48th of the shares subject to the option vest monthly thereafter.